Synthesis and Distribution of Drugs of Abuse and Related Compounds

• Synthesize and distribute both unlabeled and radiolabeled drugs of abuse (cannabinoids, hallucinogens, narcotics, stimulants, depressants, peptides, etc.). • Maintain a secure, temperature‑controlled inventory of hundreds of DEA‑controlled compounds, ensuring purity and compliance with DEA regulations. • Provide documentation of capabilities, staff expertise, prior similar contracts, and DEA registration status in a 10‑page capability statement. • Submit electronically by 1:00 PM EST, 20 Nov 2026; no paper/fax accepted.